Tue, 23.02.2016 @18:45
in Halle7 (ehemals Sicht-bar/Blindekuh Basel)
[add to iCal]
categories:
About the event
Please register for this event through the event website.
i-net & LSNB Event: «Cellestia Biotech or how to successfully launch a university spin-off into a biotech company»
Cellestia Biotech was founded in 2014 as a spin-off from the Swiss Institute for Experimental Cancer Research at EPFL, with its headquarters in Basel and research operations in Lausanne. The focus of Cellestia Biotech lays on anti-cancer drugs modulating the NOTCH pathway, with a novel, first-in-class, oral pan-NOTCH inhibitor as lead compound. The company – which is managed by a high-calibre team of academic and industry professionals – is now successfully advancing the project from the research to development stage.
This i-net/LSNB event (Halle7 in Basel, February 23nd, 19:00; door opening 18:45) will have Michael Bauer, CEO of Cellestia Biotech and an experienced industry professional, talking about this story and sharing insights and learnings along the way, especially also focussing on lesson learned on the transition from academic research to a drug development company. Also attending are Dirk Weber, CMO, and Rajwinder Lehal, CSO of Cellestia Biotech.
After the event, there will be a networking Apéro.
CV Dr. Michael Bauer
Michael Bauer, Chief Executive Officer of Cellestia Biotech, is a senior drug development professional with over 18 years of experience in the Life Sciences industry. He served in senior leadership positions across disciplines such as clinical and preclinical drug development, project & portfolio management, regulatory affairs and metabolism research. Most recent assignments were with Novartis Pharma AG, Translational Medicine Oncology, working as Senior Global Program Manager Development and Polyphor Ltd., where he served as Head of Clinical Development. Under his leadership, several new oncology drugs were brought into clinical development and reached clinical proof of concept. Michael holds a Ph.D. in Biotechnology and M.Sc. in Chemistry.